Review Article
AngiomiRs: Potential Biomarkers of Pregnancy’s Vascular Pathologies
Table 1
AngiomiRs detected in pregnancy’s vascular diseases.
| Study | Pathology | Gestation age in which miRNAs were detected (weeks) | Tissue used | Serum | Plasma | Placenta |
| [28] [83] [44]
|
PE | <20 26–40 <20
| miR-210 ↑ miR-144 ↓ (severe and mild PE) miR-29a ↑ (mild PE)
| miR-210 ↑ (severe and mild PE) miR-210 ↑
| | [33, 51] | Perinatal | | | miR-16 ↑ (severe PE) | [55] | 26 | | | miR-125b-1-3p ↑ | [31, 39] | 39-40 | | | miR-155 ↑ (severe PE) | [47] | 36 | | | miR-328 ↓ | [32] | 5–12 13–25 26–40 | | | miR-378a-5p ↓ | [38] | Perinatal | | | miR-29b ↑ (severe late onset PE) | [64] | Perinatal | | | miR-21 ↑ (early onset PE with IUGR) |
| [33] |
IUGR | Perinatal | | | miR-16 ↑ miR-21 ↑ | [69] | Perinatal | | | miR-424 ↑ |
| [72] | Gestational diabetes | Second trimester | miR-29a ↓ miR-222 ↓ miR-132 ↓ | | |
|
|
↓ indicates decrease in miRNA expression. ↑ indicates increase in miRNA expression.
|